Compare LMAT & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LMAT | GOF |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2006 | 2006 |
| Metric | LMAT | GOF |
|---|---|---|
| Price | $80.14 | $8.60 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $107.00 | N/A |
| AVG Volume (30 Days) | 188.3K | ★ 2.6M |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | ★ 30.57 | N/A |
| EPS | ★ 1.42 | N/A |
| Revenue | ★ $249,602,000.00 | N/A |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $9.54 | N/A |
| P/E Ratio | $58.69 | ★ N/A |
| Revenue Growth | ★ 13.53 | N/A |
| 52 Week Low | $78.22 | $8.40 |
| 52 Week High | $118.01 | $15.09 |
| Indicator | LMAT | GOF |
|---|---|---|
| Relative Strength Index (RSI) | 54.99 | 27.33 |
| Support Level | $82.58 | N/A |
| Resistance Level | $84.35 | $10.74 |
| Average True Range (ATR) | 1.57 | 0.14 |
| MACD | 0.71 | 0.03 |
| Stochastic Oscillator | 94.31 | 17.25 |
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The Fund's investment objective is to maximize total return through a combination of current income and capital appreciation. It has single operating segment. Its products are Mutual Funds, Wealth Management SMAS, Institutional SMAS, ETFS, UITS, UCITS, CIT, Closed-End Funds, Private Funds, Rydex Funds, and Variable Insurance funds.